Rate Control in Atrial Fibrillation with Heart Failure

Primary Recommendations

The American College of Cardiology recommends beta-blockers, particularly esmolol or metoprolol, as the preferred first-line agents for rate control in atrial fibrillation with rapid ventricular response when systolic heart failure is present 2, 3, 4, 5
Beta-blockers provide the dual benefit of rate control while also reducing hospitalization risk and mortality in heart failure patients 4
If beta-blockers cannot be tolerated, digoxin is the recommended alternative, NOT diltiazem 4

The American Heart Association guidelines explicitly state that diltiazem should be avoided in patients with heart failure and pre-existing systolic dysfunction 1, 2, 3
The European Society of Cardiology guidelines state that rate-limiting calcium channel blockers (verapamil and diltiazem) are effective alternatives to beta-blockers specifically in HFpEF patients 4
Diltiazem is an acceptable alternative to beta-blockers for rate control in patients with heart failure with preserved ejection fraction (HFpEF) 4

For HFrEF patients, use beta-blockers as first-line, with esmolol and metoprolol being preferred options 4, 5
Esmolol can be initiated with a 500 mcg/kg IV bolus over 1 minute, then 50 mcg/kg/min infusion, titrate up to 200 mcg/kg/min 5
Metoprolol can be initiated with 5 mg IV over 1-2 minutes, repeat every 5 minutes to maximum 15 mg 1

Hemodynamic instability always requires immediate electrical cardioversion, not pharmacologic rate control 2, 3, 5
When beta-blockers are initiated in HFrEF, start with low doses and monitor carefully for worsening heart failure 5
Beta-blockers themselves can initially worsen heart failure symptoms despite long-term benefits 7